Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
- Species
- Human
- Expression
- HEK293
Protein structure
KRAS G12D (25–305)
AviHis加载中…
加载中…
Search by catalog number, molecule, or alias, then narrow by species, tag, and expression system.
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg
Protein structure
| Molecule | Catalog # | Species | Host | Product Description | Protein structure |
|---|---|---|---|---|---|
| KRAS G12D | KRASG12D-HP005 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12D (25–305) AviHis |
| KRAS G12V | KRASG12V-HB003 | Human | HEK293 | Biotinylated Human HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12V (25–305) AviHis |
| MAGE-A10 | MAGEA10-HB001 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&MAGE-A10 (GLYDGMEHL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A10 (25–305) AviHis |
| HLA-A*03:01 | HLAA0301-HB004 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-A*03:01&B2M Monomer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | HLA-A*03:01 (25–305) AviHis |
| HLA-A*68:01 | HLAA6801-HB001 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-A*68:01&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*68:01 (25–305) AviHis |
| FcRn | FCRN-AB001 | Human | HEK293 | Anti-FcRn Antibody (Rozanolixizumab Biosimilar) Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | FcRn |
| MAGE-A1 | MAGEA1-HB001 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&MAGE-A1 (KVLEYVIKV) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A1 (25–305) AviHis |
| MAGE-A2 | MAGEA2-HB001 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&MAGE-A2 (KMVELVHFL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A2 (25–305) AviHis |
| Survivin 2B | SURVIVIN2B-HP003 | Human | HEK293 | Human HLA-A*24:02&B2M&Survivin 2B (AYACNTSTL) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | Survivin 2B (25–305) AviHis |
| KRAS G12D | KRASG12D-HP003 | Human | HEK293 | Human HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12D (25–305) His |
| LMP2 | LMP2-HB001 | Human | HEK293 | Biotinylated Human HLA-A*11:01&B2M&LMP2 (SSCSSCPLTK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | LMP2 (25–305) AviHis |
| HLA-A*33:03 | HLAA3303-HB002 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-A*33:03&B2M Monomer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | HLA-A*33:03 (25–305) AviHis |
| EBV LMP1 | EBVLMP1-HP001 | Human | HEK293 | Human HLA-E*01:03&B2M&EBV LMP1 (GGDPHLPTL) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | EBV LMP1 (22–302) AviHis |
| MAGE-A4 | MAGEA4-HB003 | Human | HEK293 | Biotinylated Human HLA-A*02:01&B2M&MAGE-A4 (GVYDGREHTV) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A4 (25–305) AviHis |
| MAGE-A4 | MAGEA4-HP004 | Human | HEK293 | Human HLA-A*02:01&B2M&MAGE-A4 (GVYDGREHTV) Tetramer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | MAGE-A4 (25–305) AviHis |
| LILRA1 | LILRA1-HB001 | Human | HEK293 | Biotinylated Human LILRA1/CD85i/LIR-6 Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | LILRA1 (17–461) AviHis |
| KRAS G12D | KRASG12D-HB004 | Human | HEK293 | Biotinylated Human HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | KRAS G12D (25–305) AviHis |
| HLA-A*11:01 | HLAA1101-HP005 | Human | HEK293 | Human Peptide Ready HLA-A*11:01&B2M Monomer Protein, Ultra Low Endotoxin Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 0.01 EU per μg by the LAL method. 100 μg | HLA-A*11:01 (25–305) AviHis |
| HLA-C*03:04 | HLAC0304-HB001 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-C*03:04&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-C*03:04 (25–305) AviHis |
| HLA-A*24:02 | HLAA2402-HB001 | Human | HEK293 | Biotinylated Human Peptide Ready HLA-A*24:02&B2M Monomer Protein Purity > 95% as determined by Bis-Tris PAGE > 95% as determined by HPLC Endotoxin Less than 1 EU per μg by the LAL method. 100 μg | HLA-A*24:02 (25–305) AviHis |